ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models
Lars Wallstabe(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie), Michael Hudecek(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie)
Cited by 192
Related Papers
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for <i>In Vivo</i> Antitumor Activity
|Cancer Immunology Research|2014|517
Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer
|Journal for ImmunoTherapy of Cancer|2020|142